Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms
Phase 2
Completed
- Conditions
- Gastroesophageal Reflux
- Interventions
- Drug: VECAM 40/300
- First Posted Date
- 2010-01-29
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- Vecta Ltd.
- Target Recruit Count
- 52
- Registration Number
- NCT01059383
- Locations
- 🇺🇸
Oklahoma Foundation for Digestive Research, Oklahoma City, Oklahoma, United States
🇺🇸Clinical Applications Laboratories Inc., San Diego, California, United States
Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH
- First Posted Date
- 2009-01-08
- Last Posted Date
- 2010-01-27
- Lead Sponsor
- Vecta Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT00818870
- Locations
- 🇺🇸
Clinical Applications Laboratories Inc., San Diego, California, United States
© Copyright 2025. All Rights Reserved by MedPath